NCT04618432

Brief Summary

Study Description: It may be in the interest of the NIDCD Clinical Research Program (CRP) to collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders and to evaluate patients to determine candidacy for intramural clinical studies. This protocol will provide the administrative vehicle to enable the evaluation and provision of clinical care for patients with head and neck and communication disorders by the NIDCD CRP, Clinical Center, and consult services. No investigational therapies will be administered in this study. Objectives and Endpoints: (Summation)To collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders (Summation)To evaluate patients to determine candidacy for intramural clinical studies Study Population: Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder referred to NIDCD Clinical Investigators by the Intramural Consult Service or community providers Description of Sites: NIH Clinical Center Study Duration: 10 years

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 3, 2020

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

November 5, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 6, 2020

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2023

Completed
Last Updated

June 13, 2023

Status Verified

June 1, 2023

Enrollment Period

2.6 years

First QC Date

November 5, 2020

Last Update Submit

June 12, 2023

Conditions

Keywords

CarcinomaHearingBalanceNeoplasmNatural History

Outcome Measures

Primary Outcomes (2)

  • Evaluation for clinical studies

    To evaluate patients to determine candidacy for intramural clinical studies

    ongoing

  • Clinical data collection

    To collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders

    ongoing

Study Arms (1)

Patients

Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder.

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder referred to NIDCD Clinical Investigators by the Intramural Consult Service or community providers

You may qualify if:

  • Patients must be age 2 years or older if procedures or treatment are required.
  • Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder.
  • An NIDCD clinical investigator and PI determines it is in the interest of the patient/individual and NIDCD CRP for the subject to undergo consult, treatment or follow-up at the NIDCD/NIH
  • Patient or their Legally Authorized Representative is able to provide informed consent.

You may not qualify if:

  • Candidates who in the opinion of the PI and clinical team have medical or unstable conditions for which NIDCD and CC consultative services are unable to provide or support optimal care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Links

MeSH Terms

Conditions

CarcinomaNeoplasms

Condition Hierarchy (Ancestors)

Neoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Study Officials

  • Clint T Allen, M.D.

    National Institute on Deafness and Other Communication Disorders (NIDCD)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2020

First Posted

November 6, 2020

Study Start

November 3, 2020

Primary Completion

June 7, 2023

Study Completion

June 7, 2023

Last Updated

June 13, 2023

Record last verified: 2023-06

Locations